Zahra, Mehdi
Durand-Zaleski, Isabelle
Górecki, Michal
Walleser Autiero, Silke http://orcid.org/0000-0001-8058-6555
Barnett, Gillian
Schüpbach, W. M. Michael
Funding for this research was provided by:
Medtronic International Trading Sarl
Medtronic International Trading Sarl
Medtronic International Trading
Article History
Received: 18 April 2018
Accepted: 14 February 2020
First Online: 2 March 2020
Ethics approval and consent to participate
: The original data were collected from the EARLYSTIM Trial (ExternalRef removed Identifier: ExternalRef removed) which involved obtaining written informed consent from all participants upon trial enrollment. Ethics approval was provided by ethics committees for each participating center. Raw data were obtained as anonymized patient data.
: Not applicable.
: Mehdi Zahra is an employee of Medtronic International Trading Sarl.Gillian Barnett received a consultancy fee from Medtronic International Trading Sarl for this study.Isabelle Durand-Zaleski received a consultancy fee from Medtronic International Trading Sarl for this study.Michal Górecki is an employee of Health Technology Assessment and received a consultancy fee from Medtronic International Trading Sarl for this study.Silke Walleser Autiero is an employee of Medtronic International Trading Sarl.W.M. Michael Schüpbach received a consultancy fee from Medtronic International Trading Sarl for this study and has received grants from French Programme Hospitalier de Recherche Clinique National (P050909), the German Ministry of Research (Klinische Studien 01KG0502), Boston Scientific, and Actelion, and personal fees from Merz Pharma, Zambon, Medtronic, Aleva, Boston Scientific, Allergan.